Europe’s pharma sector falling behind US and China, competitiveness drive is urgent, vital

Europe’s pharmaceutical industry added more than €311 billion to Gross Value Added across the EU-27 countries, but the EU is being massively outpaced by US and China’s R&D spending. The catch-up window is narrow and closing.Read More